Cargando…
Plasma-type gelsolin in subarachnoid hemorrhage: novel biomarker today, therapeutic target tomorrow?
There is growing interest in the potential neuroprotective properties of gelsolin. In particular, plasma-type gelsolin (pGSN) can ameliorate deleterious inflammatory response by scavenging pro-inflammatory signals such as actin and lipopolysaccharide. In a recent issue of Critical Care, Pan and coll...
Autores principales: | Chou, Sherry Hsiang-Yi, Lo, Eng H, Ning, MingMing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056622/ https://www.ncbi.nlm.nih.gov/pubmed/24393331 http://dx.doi.org/10.1186/cc13178 |
Ejemplares similares
-
Plasma gelsolin levels and outcomes after aneurysmal subarachnoid hemorrhage
por: Pan, Jian-Wei, et al.
Publicado: (2013) -
Pan-coronavirus fusion inhibitors as the hope for today and tomorrow
por: Wang, Xinling, et al.
Publicado: (2021) -
The Impact of Information Technology on Managed Care Pharmacy: Today and Tomorrow
por: Hillblom, Douglas, et al.
Publicado: (2014) -
Today and tomorrow and ...
por: Asimov, Isaac
Publicado: (1976) -
Accelerators today and tomorrow
por: EROKHIN, Alexandre
Publicado: (2014)